See how leading pharma teams monitor pricing and market access with one platform, not dozens
Book a live GPI Pulse™ demo and discover how your team can track pricing, reimbursement, HTA, IRP, and MFN risk across 60+ markets — continuously updated, instantly accessible, without the manual effort.
200M+ data points across pricing, reimbursement, HTA, and IRP — standardised into one consistent, source-transparent platform
60+ pricing markets, 100+ IRP markets — with dedicated MFN, Globe, and Guard risk capabilities built in
Trusted by Top 10 global pharma and emerging biotech — across market access, pricing, and clinical feasibility teams
No commitment required — a 30–45 minute walkthrough tailored to your therapy area and markets
Book your demo
Choose how you'd like to connect
Pick a time in the calendar, or if nothing suits, leave your details and we'll arrange something that works.
Book a time
Pick a slot that works for you
Select a time below to speak with a GPI specialist. We'll tailor the GPI Pulse™ walkthrough to your therapy area, markets, and use case — including MFN or IRP if relevant.
No commitment required — 30–45 minutes, tailored to your therapy area. Most teams book 2–3 weeks out, so the sooner you reach out the better.
Send a message
Can't find a suitable time?
Leave your details below and a member of our team will be in touch to arrange a time that works for you.
Trusted by leading pharmaceutical companies worldwide
What you'll see in your demo
The market access intelligence your team has been doing manually — done in seconds
GPI Pulse™ replaces fragmented, multi-source research with a single continuously updated platform. Here is what we cover in a tailored demo.
Pricing & reimbursement intelligence
See how GPI Pulse™ surfaces availability, reimbursement status, and net pricing data across 60+ markets in a single view — with full source transparency, historical tracking, and multi-currency conversion built in. Understand how prices have evolved for your therapy area and relevant analogues over time.
60+ pricing markets
HTA outcomes & payer decisions
Explore structured HTA data across 30+ markets — including assessment publications, clinical comparators, payer decisions, and reimbursement timelines, all linked to original source documents. Understand exactly what shaped payer perception for assets in your therapy area and how timelines compare to your own planning assumptions.
30+ HTA markets
IRP matrix & MFN risk intelligence
Walk through the IRP matrix across 100+ markets — detailing referencing rules, matched countries, price levels referenced, and policy-specific considerations. See how early launch prices enter IRP baskets over time and how this creates downstream MFN, Globe, and Guard exposure if not planned for from Day One.
100+ IRP markets
Cost of treatment analysis
See how GPI Pulse™ calculates cost of treatment per day, per month, and per annum by country and indication — giving a representative, comparable view of drug cost across markets and dosing schedules without manual calculation. Particularly useful when benchmarking across competitive analogues or modelling payer value frameworks.
60+ pricing markets
Custom alerts & policy monitoring
Discover how to set up proactive alerts by country, therapy class, indication, or event type — including policy-driven changes relevant to MFN, Globe, Guard, or IRP rule updates. Stay informed the moment something changes in your space without manually monitoring sources across multiple markets.
60+ markets
Launch trends, reporting & data feeds
See how launch country trend tools, custom reporting templates, and configurable data feeds allow your team to generate outputs and connect GPI Pulse™ intelligence directly into your internal workflows — eliminating repetitive manual export steps and enabling end-to-end integration across your pricing governance process.
60+ markets
200M+Data points across pricing, reimbursement, HTA & IRP
My experience with GPI is overall very good. GPI Pulse™ provides detailed information about pricing and reimbursement landscape across multiple countries. In studies where we need to classify countries based on reimbursement status, GPI is an essential source.
Global Feasibility LeadFortrea
Frequently asked questions
Questions about GPI Pulse™ or your demo
Everything you need to know before your call.
What is GPI Pulse™?
+
GPI Pulse™ is GPI's subscription-based pharmaceutical pricing and market access intelligence platform. It brings together pricing, reimbursement, HTA, and IRP data across 60+ pricing markets and 100+ IRP markets into one continuously updated, standardised platform — eliminating the need to manually track multiple sources across different countries and languages. Used by market access teams, pricing specialists, and clinical feasibility teams at Top 10 global pharma companies and emerging biotech.
Who is a GPI Pulse™ demo suitable for?
+
GPI Pulse™ is used by market access teams, pricing and market access directors, pricing specialists, clinical and feasibility teams, and portfolio strategy leads. It is valuable at all stages of the drug development pipeline — from early competitive landscape analysis and analogue identification through to post-launch competitive monitoring and policy surveillance. It is particularly relevant for teams navigating MFN, Globe, or Guard policy changes requiring rapid portfolio assessment.
How long does a GPI Pulse™ demo take?
+
A live GPI Pulse™ demo typically runs for 30 to 45 minutes. We tailor the walkthrough to your specific therapy area, markets of interest, and use case — whether that is competitive monitoring, IRP intelligence, MFN, Globe, or Guard risk management, HTA tracking, or launch feasibility. We are happy to focus the demo wherever it is most valuable to your team.
What markets does GPI Pulse™ cover?
+
GPI Pulse™ covers pricing and reimbursement data across 60+ markets, HTA assessment data across 30+ markets, and IRP reference pricing intelligence across 100+ markets. This includes strong depth across the EU5 (Germany, France, Italy, Spain, and the UK), the United States, APAC, the GCC, and the Nordics. Data is standardised into a consistent format and translated where needed, so global teams can compare markets side by side without in-country language capabilities.
How does GPI Pulse™ help with MFN, Globe, and Guard risk?
+
MFN exposure is not accidental — it is created by the launch and pricing decisions teams make during development. GPI Pulse™ provides the IRP intelligence across 100+ markets and global launch sequence data your team needs to identify how early launch prices enter IRP baskets and when they are likely to be picked up by referencing markets. This allows teams to model alternative launch sequences and build MFN, Globe, and Guard considerations into planning from Day One — before flexibility is lost.
Is there a commitment required to book a demo?
+
None at all. The demo is exploratory and carries no obligation. We will walk through the platform capabilities relevant to your therapy area and markets, and if there is a clear fit, we will discuss what a GPI Pulse™ subscription would look like for your team. If there is not, we will tell you that too.
